Vestal Point Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-500,000
| Closed | -$18.1M | – | 82 |
|
|
2025
Q1 | $18.1M | Sell |
500,000
-1,000,000
| -67% | -$36.2M | 1.29% | 25 |
|
|
2024
Q4 | $63.1M | Buy |
1,500,000
+750,000
| +100% | +$31.6M | 3.74% | 5 |
|
|
2024
Q3 | $41.7M | Sell |
750,000
-1,050,000
| -58% | -$58.3M | 3.16% | 10 |
|
|
2024
Q2 | $74M | Buy |
1,800,000
+1,690,000
| +1,536% | +$69.5M | 5.52% | 4 |
|
|
2024
Q1 | $5.14M | Buy |
+110,000
| New | +$5.14M | 0.42% | 45 |
|